Related Experiment Video
Updated: Mar 6, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Combination nicotine replacement therapy: strategies for initiation and tapering
Stephanie L Hsia1, Mark G Myers2, Timothy C Chen2
1VA San Diego Healthcare System (VASDHS), 3350 La Jolla Village Drive (119), San Diego, CA 92161, USA.
Combination nicotine replacement therapy (NRT) effectively aids smoking cessation. This review clarifies combination NRT dosing and proposes a tapering strategy, integrating behavioral support for successful quitting.
Area of Science:
- Addiction Medicine
- Pharmacology
- Behavioral Science
Background:
- Combination nicotine replacement therapy (NRT) is proven effective for smoking cessation.
- Limited guidance exists on initiating and tapering combination NRT regimens.
- Evidence-based strategies are needed to optimize treatment protocols.
Purpose of the Study:
- To review the evidence and rationale for combination NRT.
- To present dosing strategies employed in combination NRT studies.
- To propose a structured tapering approach for combination NRT, incorporating behavioral support.
Main Methods:
- Literature review of existing studies and meta-analyses on combination NRT.
- Analysis of dosing regimens used in clinical trials.
- Synthesis of evidence to formulate a tapering protocol.
Main Results:
- Combination NRT demonstrates significant efficacy in smoking cessation.
- Established dosing patterns exist, though variability is noted.
- A step-down tapering approach can be effectively implemented.
Conclusions:
- Combination NRT is a valuable tool for smoking cessation.
- Standardized guidance on initiation and tapering is beneficial.
- Integrating behavioral strategies enhances the effectiveness of NRT tapering.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
06:12Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Oral Drug Delivery Systems: Continuous-Release Systems
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation